In correlation with its involvement in MT, but also cell survival and DNA repair mechanisms, TG2 was found to affect the therapy-resistant phenotype of different cancer types [29,31,32], including malignant melanoma, an aggressive tumor, highly resistant to standard chemo- and radiotherapy. This evidence concerns the gene TGM2 and neoplasm.